Guardian Pharmacy Services, Inc. GRDN
Retail-Drug Stores and Proprietary Stores · CIK 0001802255 · Fiscal year ends 1231
Revenue
$1.45B
Fiscal year ended 2025-12-31Operating income
$72.70M
Fiscal year ended 2025-12-31Free cash flow
—Unavailable
Fiscal year ended 2025-12-31Valuation, from the filing
| Public float | $411.60M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|
| Float / net income | 8.4× | A lower bound on the multiple, because affiliate holdings are excluded. |
|---|
| Float / revenue | 0.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
|---|
| Float / equity | 1.9× | A lower bound on the multiple, because affiliate holdings are excluded. |
|---|
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $1.45B and net income of $49.22M for the fiscal year ended 2025-12-31. This page shows 2 annual periods of income statement, balance sheet and cash flow figures normalized from Guardian Pharmacy Services, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Retail-Drug Stores and Proprietary Stores.
Income
Balance
Cash flow
Derived
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GRDN in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.